UK markets closed

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
742.90-5.90 (-0.79%)
At close: 04:59PM CEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
149,027,000
140,800,000
126,946,000
122,021,000
111,831,000
Cost of revenue
24,764,000
23,658,000
20,932,000
20,088,000
17,617,000
Gross profit
124,263,000
117,142,000
106,014,000
101,933,000
94,214,000
Operating expenses
Research development
19,034,000
17,772,000
15,462,000
14,220,000
14,805,000
Selling general and administrative
43,023,000
41,058,000
36,886,000
35,830,000
33,313,000
Total operating expenses
61,454,000
58,498,000
51,888,000
49,450,000
46,966,000
Operating income or loss
62,809,000
58,644,000
54,126,000
52,483,000
47,248,000
Interest expense
930,000
289,000
390,000
220,000
85,000
Total other income/expenses net
-
616,000
-793,000
-3,494,000
473,000
Income before tax
61,061,000
59,080,000
53,130,000
48,553,000
47,615,000
Income tax expense
11,717,000
11,323,000
10,992,000
9,602,000
8,987,000
Income from continuing operations
49,344,000
47,757,000
42,138,000
38,951,000
38,628,000
Net income
49,344,000
47,757,000
42,138,000
38,951,000
38,628,000
Net income available to common shareholders
49,344,000
47,757,000
42,138,000
38,951,000
38,628,000
Basic EPS
-
20.79
18.05
16.41
15.96
Diluted EPS
-
20.74
18.01
16.38
15.93
Basic average shares
-
2,297,114
2,333,900
2,374,299
2,419,603
Diluted average shares
-
2,302,652
2,340,000
2,378,658
2,424,417
EBITDA
-
65,394,000
59,273,000
54,434,000
51,625,000